3 completed. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow Aggredyne, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of AggreGuide A-100 (ADP) Assay P2Y12 inhibitor, Platelet function test - Risk Factor, Cardiovascular, Platelet Dysfunction Due to Drugs | Not applicable | Completed | Aggredyne, Inc. | 280 | 2017-01-09 | 2019-02-21 |
| Aggreguide A-100 ADP Assay Evaluation platelet aggregation measurement - Platelet Aggregation, ADP Blockers | Completed | Aggredyne, Inc. | 150 | 2014-03-01 | 2017-04-04 | |
| AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction Platelet Dysfunction Due to Aspirin Ingestion | Completed | Aggredyne, Inc. | 150 | 2013-04-01 | 2013-08-02 |
Clopidogrel (1) · Platelet Aggregation (1) · Platelet Function Tests (1) · Prasugrel Hydrochloride (1) · Ticagrelor (1)
United States (2)
Edward Teitel, MD (1) · Phil Speros (1)